Fountain Therapeutics is building a pipeline of therapeutics to treat age-related diseases by reversing cellular age. The company has combined the expertise of leaders in aging research and computation to build an AI-driven platform that extracts previously hidden cellular features to measure aging with remarkable precision. Fountain is currently screening a large diversity of drug compounds, including small molecules and biologics, to identify novel drugs that specifically reverse the age of cells for the development of therapeutics to treat age-related diseases.
Fountain is comprised of an exceptional growing team of scientists, engineers, physicians, drug hunters and developers, and entrepreneurs originating from top academic institutions, research laboratories and biotech companies in the world. The team is united by the common goal of building a new way forward to decouple aging from disease and improve the quality of life for our aging population.
Fountain is based in South San Francisco, California. For more information on Fountain, please visit www.fountaintx.com.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 681 Gateway Blvd, South San Francisco,california 94080,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- fountaintx.com
- HQ
- South San Francisco, California
Fountain Therapeutics Questions
Fountain Therapeutics's website is fountaintx.com
Fountain Therapeutics's LinkedIn profile is https://www.linkedin.com/company/fountaintx
Fountain Therapeutics has
4 employees.
View email and phone details for 4
employees at Fountain Therapeutics.
Fountain Therapeutics's industry is
Biotechnology Research
Fountain Therapeutics's top competitors are
Athos Therapeutics Inc,
Bioage Labs,
Ainnocence,
Nitrase Therapeutics,
Hexagon Bio,
Maplight Therapeutics, Inc.,
Genesis Therapeutics,
Terray Therapeutics,
Soteria Biotherapeutics,
Ltz Therapeutics.
Fountain Therapeutics's categories are Biotechnology Research
Fountain Therapeutics's founding year is 2018
